COLAIANNI, GRAZIANA
 Distribuzione geografica
Continente #
NA - Nord America 7.929
AS - Asia 3.551
EU - Europa 2.933
SA - Sud America 932
AF - Africa 264
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 15.629
Nazione #
US - Stati Uniti d'America 7.782
SG - Singapore 1.441
IT - Italia 904
CN - Cina 807
BR - Brasile 710
SE - Svezia 437
HK - Hong Kong 376
RU - Federazione Russa 354
DE - Germania 274
VN - Vietnam 269
FR - Francia 219
FI - Finlandia 206
GB - Regno Unito 161
CI - Costa d'Avorio 141
IN - India 132
UA - Ucraina 131
AR - Argentina 70
ID - Indonesia 69
CA - Canada 68
BD - Bangladesh 67
JP - Giappone 56
TR - Turchia 52
MX - Messico 49
CO - Colombia 44
NL - Olanda 43
IQ - Iraq 41
PK - Pakistan 38
ES - Italia 36
PL - Polonia 35
BE - Belgio 34
ZA - Sudafrica 32
MA - Marocco 28
EC - Ecuador 26
SA - Arabia Saudita 26
VE - Venezuela 25
AE - Emirati Arabi Uniti 20
IE - Irlanda 19
PH - Filippine 18
UZ - Uzbekistan 18
MY - Malesia 17
PE - Perù 17
PY - Paraguay 16
CL - Cile 15
AU - Australia 14
EG - Egitto 13
TH - Thailandia 13
AT - Austria 12
ET - Etiopia 11
IR - Iran 11
JM - Giamaica 11
TN - Tunisia 11
KE - Kenya 10
KR - Corea 10
OM - Oman 10
CZ - Repubblica Ceca 9
LT - Lituania 9
AZ - Azerbaigian 8
JO - Giordania 8
IL - Israele 7
DO - Repubblica Dominicana 6
PS - Palestinian Territory 6
SI - Slovenia 6
UY - Uruguay 6
AL - Albania 5
DZ - Algeria 5
KG - Kirghizistan 5
AO - Angola 4
BY - Bielorussia 4
CY - Cipro 4
DK - Danimarca 4
HR - Croazia 4
LB - Libano 4
PA - Panama 4
TW - Taiwan 4
EU - Europa 3
GR - Grecia 3
NO - Norvegia 3
NP - Nepal 3
RS - Serbia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
HN - Honduras 2
HU - Ungheria 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
AM - Armenia 1
AQ - Antartide 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BW - Botswana 1
Totale 15.615
Città #
Ashburn 894
Fairfield 806
Singapore 774
Woodbridge 568
San Jose 513
Chandler 455
Houston 434
Bari 374
Hong Kong 374
Nyköping 350
Cambridge 346
Seattle 344
Ann Arbor 305
Wilmington 279
Jacksonville 276
Beijing 247
Dallas 211
Abidjan 141
Helsinki 121
New York 116
Lauterbourg 110
Roxbury 106
Nanjing 105
Los Angeles 103
Lawrence 97
Munich 82
Ho Chi Minh City 79
Des Moines 74
Brooklyn 68
Hanoi 68
Grumo Appula 66
Santa Clara 63
Inglewood 58
Council Bluffs 52
Jakarta 49
Boardman 47
São Paulo 47
Princeton 43
Chicago 40
San Diego 37
Milan 36
Buffalo 35
London 35
Tokyo 35
Brussels 34
Trani 33
Rome 32
Frankfurt am Main 30
Shenyang 30
Warsaw 30
Falkenstein 29
Jiaxing 28
Rio de Janeiro 28
Dearborn 26
Montreal 26
Orem 26
Dong Ket 25
Mexico City 25
Baghdad 24
Pune 24
Redwood City 24
Nanchang 23
Hebei 22
Paris 22
The Dalles 21
Moscow 20
Changsha 19
San Francisco 19
Atlanta 18
Dublin 18
Noicattaro 18
Tianjin 18
Toronto 18
Poplar 17
Tashkent 17
Falls Church 16
Manchester 16
Johannesburg 15
Turku 15
Ankara 14
Brasília 14
Chennai 14
Columbus 14
Nuremberg 14
Amsterdam 13
Guangzhou 13
Phoenix 13
Shanghai 13
Zhengzhou 13
Campinas 12
Charlotte 12
Dhaka 12
Lima 12
Mumbai 12
Stockholm 12
Caracas 11
Denver 11
Haiphong 11
Istanbul 11
Salt Lake City 11
Totale 10.531
Nome #
Irisin prevents microgravity-induced impairment of osteoblast differentiation in vitro during the space flight CRS-14 mission 280
The myokine irisin increases cortical bone mass 228
Impairment of bone remodeling in LIGHT/TNFSF14-deficient mice 226
Irisin serum levels are positively correlated with bone mineral status in a population of healthy children 222
Effects of sweet cherry polyphenols on enhanced osteoclastogenesis associated with childhood obesity 214
Functions of vasopressin and oxytocin in bone mass regulation 208
Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice 208
High Sclerostin and Dickkopf-1 (DKK-1) serum levels in children and adolescents with type 1 diabetes mellitus 201
Irisin and Bone: From Preclinical Studies to the Evaluation of Its Circulating Levels in Different Populations of Human Subjects 201
LIGHT/TNFSF14 as a new biomarker of bone disease in multiple myeloma patients experiencing therapeutic regimens 193
Crosstalk Between Muscle and Bone Via the Muscle-Myokine Irisin 187
An update on the role of RANKL–RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases 184
Irisin levels correlate with bone mineral density in soccer players 176
Irisin Correlates Positively With BMD in a Cohort of Older Adult Patients and Downregulates the Senescent Marker p21 in Osteoblasts 173
Osteogenic differentiation of mesenchymal stem cells from dental bud: Role of integrins and cadherins 171
Deletion of the Transcription Factor PGC-1α in Mice Negatively Regulates Bone Mass 169
Sclerostin stimulates angiogenesis in human endothelial cells 165
Mechanisms involved in childhood obesity-related bone fragility 165
Monoclonal antibodies for treating osteoporosis 163
A Novel Mechanism of Signal Transduction: Oxytocin Receptors Activated by the Ligand Translocate in the Nucleus to Enhance Osteoblast Transcription 159
Irisin Prevents Disuse-Induced Osteocyte Apoptosis 158
Oxytocin receptor nuclear translocation mediates upregulation of osteoblast specific genes 157
High irisin levels are associated with better glycemic control and bone health in children with Type 1 diabetes 155
Irisin and musculoskeletal health 153
Stemness genes expression in naïve vs. osteodifferentiated human dental-derived stem cells 149
Bone Marrow Oxytocin Mediates the Anabolic Action of Estrogen on the Skeleton 148
Human myeloma cell lines induce osteoblast down-regulation of CD99 which is involved in osteoblast formation and activity 143
Light/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease. 142
The effects of bone pâté on human osteoblasts cell cultures 141
A new titanium biofunctionalized interface based on poly(pyrrole-3-acetic acid) coating: proliferation of osteoblast-like cells and future perspectives 141
High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment 137
A Novel Mechanism of Signal Transduction: Oxytocin Receptors Activated by the Ligand translocate in the Nucleus to enhance Osteoblast Specific Transcription 136
LIGHT/TNFSF14 Promotes Osteolytic Bone Metastases in Non-small Cell Lung Cancer Patients 130
THE ROLE OF LIGHT ON BONE REMODELING 128
Role of Irisin on the bone-muscle functional unit 126
FSH and TSH in the regulation of bone mass: the pituitary/immune/bone axis 126
In vitro osteoclastogenesis and bone resorption during spaceflight 125
Myokines and Osteokines in the Pathogenesis of Muscle and Bone Diseases 124
Osteotropic Cancers: From Primary Tumor to Bone 123
The effect of Irisin on bone cells in vivo and in vitro 123
Oxytocin is an Anabolic Bone Hormone 121
Regulated production of the pituitary hormone oxytocin from murine and human osteoblasts 121
Irisin Treatment Prevents Isoproterenol-Induced Cardiac Fibrosis in Mice 120
Irisin Serum Levels and Skeletal Muscle Assessment in a Cohort of Charcot-Marie-Tooth Patients 120
Dominant gender-non-specific direct regulation of osteoblasts and osteoclasts by the pituitary hormone oxytocin 120
null 120
Mechanisms of Altered Bone Remodeling in Multiple Myeloma 120
Irisin Modulates Inflammatory, Angiogenic, and Osteogenic Factors during Fracture Healing 119
Irisin for care and prevention of osteoporosis 119
In Reply to the Letter to the Editor: Involvement of Irisin in Age-Related Osteoporosis and Its Inhibitory Effect on the Senescent Marker p21 in Osteoblasts 118
A novel interplay between irisin and PTH: from basic studies to clinical evidence in hyperparathyroidism 117
High expression of TRAIL by osteoblastic differentiated dental pulp stem cells affects myeloma cell viability 115
Effects of extracorporeal shock waves on murine calvaria osteoblastic cells 114
The OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 114
Skeleton and glucose metabolism: a bone-pancreas loop 114
Irisin Serum Levels in Metabolic Syndrome Patients Treated with Three Different Diets: A Post-Hoc Analysis from a Randomized Controlled Clinical Trial 114
T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction 114
Anatomy and physiology of skeletal tissue: The bone cells 114
Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis 113
Antidepressant Effect of Intermittent Long‐Term Systemic Administration of Irisin in Mice 113
LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss 112
Irisin promotes growth, migration and matrix formation in human periodontal ligament cells 112
The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 111
Irisin for care and prevention of osteoporosis 109
LIGHT as regulator of bone homeostasis during osteolytic bone metastasis formation in non-small cell lung cancer patients 109
Oxytocin: an estrogen-controlled autocrine-paracrine modulator of osteoclastogenesis and bone resorption 108
Irisin prevents trabecular bone damage and tumor invasion in a mouse model of multiple myeloma 108
The Role of LIGHT in Multiple Myeloma-Bone Disease 107
Oxytocin decreases bone resorption upregulating nitric oxide synthase isoforms 106
Microgravity during spaceflight directly affects in vitro osteoclastogenesis and bone resorption 105
CELLULAR MECHANISMS OF BONE REGENERATION: ROLE OF WNT-1 IN BONE-MUSCLE INTERACTION DURING PHYSICAL ACTIVITY 105
Myokine Irisin and Its Effects Linking Bone and Muscle Function 104
Impact of 10-day bed rest on serum levels of irisin and markers of musculoskeletal metabolism 103
T cells support the in vitro formation of osteoclasts in multiple myeloma-bone disease: the role of OPG/TRAIL interaction 102
Irisin and Secondary Osteoporosis in Humans 101
Irisin Protects against Loss of Trabecular Bone Mass and Strength in Adult Ovariectomized Mice by Stimulating Osteoblast Activity 100
Anatomy and physiology of adipose tissue 100
T cells support the osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease 99
Human osteoclasts express oxytocin receptor 98
Lack of oxytocin retards osteoblast differentiation and bone formation 97
Bone Cells 97
Increased osteoclast activity in the presence of increased homocysteine concentrations 96
null 96
Increased osteoclast differentiation and bone resorption during space flight 93
Irisin for care and prevention of osteoporosis 92
Once-Daily Subcutaneous Irisin Administration Mitigates Depression- and Anxiety-like Behavior in Young Mice 91
Short-Term Irisin Treatment Enhanced Neurotrophin Expression Differently in the Hippocampus and the Prefrontal Cortex of Young Mice 91
The novel role of PGC1α in bone metabolism 91
Oxytocin Receptor Nuclear Translocation Could Be A Novel Mechanism Mediating Osteoblast Differentiation Induced By Oxytocin 90
Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance 90
Time-dependent unloading effects on muscle and bone and involvement of FNDC5/irisin axis 89
In vitro bone resorption during Spaceflight 89
T cell-regulation of osteoclast formation and survival involving OPG/TRAIL interaction in an vitro model from human multiple myeloma 89
Systemic Administration of Recombinant Irisin Accelerates Fracture Healing in Mice 89
Irisin Levels in Cerebrospinal Fluid Correlate with Biomarkers and Clinical Dementia Scores in Alzheimer Disease 89
Irisin, the novel myokine responsible for benefits of physical exercise on bone 88
Irisina per la cura e la prevenzione dell'osteoporosi 87
null 86
The myokine Irisin recapitulates the effect of physical activity on bone and muscle tissues 85
null 85
Totale 12.897
Categoria #
all - tutte 61.515
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.515


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021374 0 0 0 0 0 0 0 0 0 180 108 86
2021/2022959 71 85 10 29 45 82 28 37 96 68 163 245
2022/20231.366 181 169 97 88 135 190 33 156 233 14 29 41
2023/2024660 57 97 32 57 83 145 35 23 21 34 15 61
2024/20252.730 147 30 177 89 62 297 403 221 108 197 340 659
2025/20265.415 857 331 560 592 653 368 574 278 695 507 0 0
Totale 16.109